Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PFIZER INC
Report date February 24, 2005 · Filed February 28, 2005
Section 16 reporting ended · disclosed 2005-02-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,507 |
Ending reported balance
After 2005-02-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2005-02-24 · Grant · Acquired 6,180 · Balance 15,946 F1: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Row 2 · 2005-02-24 · Tax withholding · Disposed 2,439 · Balance 13,507 |
| Common StockSEC Table I · non-derivative | IndirectBy Rule 16b-3 Plan | 625 |
Reported balance
Holding disclosure · report date 2005-02-24 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 625 |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction constitutes the earn-out of Performance-Contingent Shares.
SpartanNash Co
Report date June 09, 2022 · Filed June 10, 2022
Section 16 reporting ended · disclosed 2022-06-10. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2022 Filed Mar 3, 2022 16:10 UTC | SpartanNash Co SPTN · Entity 75078 | GrantCommon Stock | 4,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000905729-22-000062 · ownership.xml · nonDerivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,673 F1 · security: Reports the grant of shares of restricted stock under the SpartanNash Company 2020 Stock Incentive Plan ("Plan"). These shares will vest on March 1, 2023. Prior to vesting, these shares will remain subject to restrictions in accordance with the Plan and the terms of the grant. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 16:41 UTC | SpartanNash Co SPTN · Entity 75078 | GrantCommon Stock | 7,047 | $0.00 | $0.00 |
DisclosureSEC source: 0000905729-21-000053 · ownership.xml · nonDerivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,053 F1 · security: Reports the grant of shares of restricted stock under the SpartanNash Company 2020 Stock Incentive Plan ("Plan"). These shares will vest on March 4, 2022. Prior to vesting, these shares will remain subject to restrictions in accordance with the Plan and the terms of the grant. Read SEC document |
| December 07, 2020 Filed Dec 7, 2020 16:30 UTC | SpartanNash Co SPTN · Entity 75078 | GiftCommon Stock | 5,062 | $0.00 | $0.00 |
DisclosureSEC source: 0000905729-20-000250 · ownership.xml · nonDerivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,006 Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 16:01 UTC | SpartanNash Co SPTN · Entity 75078 | SaleCommon Stock | 2,652 | $19.32 | $51,236.64 |
DisclosureSEC source: 0000905729-20-000248 · ownership.xml · nonDerivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,068 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 16:10 UTC | SpartanNash Co SPTN · Entity 75078 | GrantCommon Stock | 5,839 | $0.00 | $0.00 |
DisclosureSEC source: 0000905729-20-000124 · ownership.xml · nonDerivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,720 F1 · security: Reports the grant of shares of restricted stock under the SpartanNash Company 2020 Stock Incentive Plan ("Plan"). These shares will vest on May 26, 2021. Prior to vesting, these shares will remain subject to restrictions in accordance with the Plan and the terms of the grant. Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 16:42 UTC | SpartanNash Co SPTN · Entity 75078 | GiftCommon Stock | 1,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000905729-19-000061 · ownership.xml · nonDerivative · entry 2 JACKSON YVONNE R · CIK 0001098930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,881 Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 16:42 UTC | SpartanNash Co SPTN · Entity 75078 | SaleCommon Stock | 1,800 | $18.33 | $32,994.00 |
DisclosureSEC source: 0000905729-19-000061 · ownership.xml · nonDerivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,081 F1 · security: Represents the aggregate number of shares sold at a weighted average price of $18.33. The actual sales prices ranged from $18.29 to $18.42, rounded to the nearest whole cent. Details regarding aggregated sales transactions will be provided upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:03 UTC | SpartanNash Co SPTN · Entity 75078 | GrantCommon Stock | 6,586 | $0.00 | $0.00 |
DisclosureSEC source: 0000905729-19-000048 · ownership.xml · nonDerivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,881 F1 · security: Reports the grant of shares of restricted stock under the SpartanNash Company Stock Incentive Plan of 2015 ("Plan"). These shares will vest on March 1, 2020. Prior to vesting, these shares will remain subject to restrictions in accordance with the Plan and the terms of the grant. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 16:30 UTC | SpartanNash Co SPTN · Entity 75078 | GrantCommon Stock | 6,262 | $0.00 | $0.00 |
DisclosureSEC source: 0000905729-18-000050 · jackson4_030518.xml · nonDerivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,295 F1 · security: Reports the grant of shares of restricted stock under the SpartanNash Company Stock Incentive Plan of 2015 ("Plan"). These shares will vest on March 1, 2019. Prior to vesting, these shares will remain subject to restrictions in accordance with the Plan and the terms of the grant. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 16:06 UTC | SpartanNash Co SPTN · Entity 75078 | GiftCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000905729-17-000132 · jackson4_031617.xml · nonDerivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,033 F1 · security: Reports the bona fide gift of stock to a charitable organization. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 16:02 UTC | SpartanNash Co SPTN · Entity 75078 | SaleCommon Stock | 3,050 | $32.56 | $99,308.00 |
DisclosureSEC source: 0000905729-17-000127 · jackson4_031017.xml · nonDerivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,283 F1 · security: Represents the aggregate number of shares sold at a weighted average price of $32.56. The actual sales prices ranged from $32.51 to $32.63, rounded to the nearest whole cent. Details regarding aggregated sales transactions will be provided upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:13 UTC | SpartanNash Co SPTN · Entity 75078 | GrantCommon Stock | 3,009 | $0.00 | $0.00 |
DisclosureSEC source: 0000905729-17-000105 · jackson4_030317.xml · nonDerivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,333 F1 · security: Reports the grant of shares of restricted stock under the SpartanNash Company Stock Incentive Plan of 2015 ("Plan"). These shares will vest on March 1, 2018. Prior to vesting, these shares will remain subject to restrictions in accordance with the Plan and the terms of the grant. Read SEC document |
| February 24, 2005 Filed Feb 28, 2005 20:09 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 2,439 | $26.20 | $63,901.80 |
DisclosureSEC source: 0000078003-05-000045 · jac874.xml · nonDerivative · entry 2 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,507 Read SEC document |
| February 24, 2005 Filed Feb 28, 2005 20:09 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 6,180 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-05-000045 · jac874.xml · nonDerivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,946 F1 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| December 31, 2004 Filed Jan 4, 2005 19:18 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 39 | $26.89 Strike: $0.00 | $1,048.71 |
DisclosureSEC source: 0000078003-05-000006 · jac850.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078 Underlying: Common Stock · 39 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2004 Filed Dec 17, 2004 19:07 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 37 | $28.32 Strike: $0.00 | $1,047.84 |
DisclosureSEC source: 0000078003-04-000376 · jac839.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,039 Underlying: Common Stock · 37 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 30, 2004 Filed Dec 2, 2004 14:37 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 38 | $27.77 Strike: $0.00 | $1,055.26 |
DisclosureSEC source: 0000078003-04-000356 · jac827.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,002 Underlying: Common Stock · 38 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 15, 2004 Filed Nov 17, 2004 18:39 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 45 | $27.62 Strike: $0.00 | $1,242.90 |
DisclosureSEC source: 0000078003-04-000342 · jac814.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 964 Underlying: Common Stock · 45 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 29, 2004 Filed Nov 2, 2004 15:53 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 36 | $28.95 Strike: $0.00 | $1,042.20 |
DisclosureSEC source: 0000078003-04-000324 · jac802.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919 Underlying: Common Stock · 36 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2004 Filed Oct 19, 2004 13:47 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 37 | $28.50 Strike: $0.00 | $1,054.50 |
DisclosureSEC source: 0000078003-04-000313 · jac792.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 883 Underlying: Common Stock · 37 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2004 Filed Oct 4, 2004 13:00 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 35 | $30.60 Strike: $0.00 | $1,071.00 |
DisclosureSEC source: 0000078003-04-000299 · jac782.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846 Underlying: Common Stock · 35 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2004 Filed Sep 17, 2004 14:24 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 33 | $31.85 Strike: $0.00 | $1,051.05 |
DisclosureSEC source: 0000078003-04-000273 · jac763.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 811 Underlying: Common Stock · 33 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 31, 2004 Filed Sep 1, 2004 17:19 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 32 | $32.67 Strike: $0.00 | $1,045.44 |
DisclosureSEC source: 0000078003-04-000260 · jac753.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 778 Underlying: Common Stock · 32 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 13, 2004 Filed Aug 17, 2004 17:17 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 38 | $31.15 Strike: $0.00 | $1,183.70 |
DisclosureSEC source: 0000078003-04-000246 · jac743.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 746 Underlying: Common Stock · 38 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| July 30, 2004 Filed Aug 2, 2004 19:13 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 33 | $31.96 Strike: $0.00 | $1,054.68 |
DisclosureSEC source: 0000078003-04-000232 · jac733.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 708 Underlying: Common Stock · 33 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| July 15, 2004 Filed Jul 19, 2004 15:41 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 33 | $32.58 Strike: $0.00 | $1,075.14 |
DisclosureSEC source: 0000078003-04-000214 · jac722.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675 Underlying: Common Stock · 33 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 30, 2004 Filed Jul 1, 2004 17:48 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 31 | $34.28 Strike: $0.00 | $1,062.68 |
DisclosureSEC source: 0000078003-04-000202 · jac712.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 642 Underlying: Common Stock · 31 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 15, 2004 Filed Jun 16, 2004 19:42 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 30 | $35.09 Strike: $0.00 | $1,052.70 |
DisclosureSEC source: 0000078003-04-000170 · jac693.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611 Underlying: Common Stock · 30 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 28, 2004 Filed Jun 2, 2004 15:15 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 30 | $35.34 Strike: $0.00 | $1,060.20 |
DisclosureSEC source: 0000078003-04-000155 · jac680.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581 Underlying: Common Stock · 30 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 14, 2004 Filed May 18, 2004 14:17 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 32 | $35.60 Strike: $0.00 | $1,139.20 |
DisclosureSEC source: 0000078003-04-000137 · jac664.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 551 Underlying: Common Stock · 32 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 30, 2004 Filed May 4, 2004 16:40 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 30 | $35.76 Strike: $0.00 | $1,072.80 |
DisclosureSEC source: 0000078003-04-000116 · jac653.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519 Underlying: Common Stock · 30 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 15, 2004 Filed Apr 19, 2004 15:21 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 30 | $37.34 Strike: $0.00 | $1,120.20 |
DisclosureSEC source: 0000078003-04-000090 · jac628.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489 Underlying: Common Stock · 30 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| March 31, 2004 Filed Apr 2, 2004 18:09 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 28 | $35.05 Strike: $0.00 | $981.40 |
DisclosureSEC source: 0000078003-04-000078 · jac619.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459 Underlying: Common Stock · 28 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| March 12, 2004 Filed Mar 16, 2004 18:02 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 254 | $35.29 Strike: $0.00 | $8,963.66 |
DisclosureSEC source: 0000078003-04-000050 · jac593.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 Underlying: Common Stock · 254 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| February 26, 2004 Filed Mar 1, 2004 20:45 UTC | PFIZER INC PFE · Entity 2863 | GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $37.15 | $0.00 |
DisclosureSEC source: 0000078003-04-000036 · jac576.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2014-02-26 F1 · derivative.exercise_date: This option becomes exercisable in three equal annual installments beginning on February 26, 2007. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 16:44 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 28 | $35.33 | $989.24 |
DisclosureSEC source: 0000078003-04-000004 · jac546.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177 Underlying: Common Stock · 28 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 29 | $34.44 | $998.76 |
DisclosureSEC source: 0000078003-03-000311 · jac536.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149 Underlying: Common Stock · 29 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:25 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 29 | $33.83 | $981.07 |
DisclosureSEC source: 0000078003-03-000298 · jac524.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120 Underlying: Common Stock · 29 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 18:30 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 37 | $34.08 | $1,260.96 |
DisclosureSEC source: 0000078003-03-000282 · jac509.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91 Underlying: Common Stock · 37 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 31, 2003 Filed Nov 4, 2003 16:01 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 27 | $31.60 | $853.20 |
DisclosureSEC source: 0000078003-03-000257 · jac498.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54 Underlying: Common Stock · 27 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2003 Filed Oct 16, 2003 15:47 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 27 | $30.60 | $826.20 |
DisclosureSEC source: 0000078003-03-000237 · jac487.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27 Underlying: Common Stock · 27 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.